Clear Street Markets LLC Global Blood Therapeutics, Inc. Transaction History
Clear Street Markets LLC
- $379 Million
- Q3 2024
A detailed history of Clear Street Markets LLC transactions in Global Blood Therapeutics, Inc. stock. As of the latest transaction made, Clear Street Markets LLC holds 50,000 shares of GBT stock, worth $0. This represents 0.25% of its overall portfolio holdings.
Number of Shares
50,000Holding current value
$0% of portfolio
0.25%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding GBT
# of Institutions
8Shares Held
288KCall Options Held
0Put Options Held
0-
Roosevelt Investment Group LLC147KShares$00.72% of portfolio
-
Jefferies Group LLC New York, NY46.3KShares$00.03% of portfolio
-
S. Muoio & Co. LLC New York, NY40.7KShares$03.66% of portfolio
-
Taylor Wealth Management Partners Boston, MA27.9KShares$00.51% of portfolio
-
Sarissa Consulting LLC Santa Monica, CA26KShares$01.83% of portfolio
About Global Blood Therapeutics, Inc.
- Ticker GBT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 67,476,200
- Market Cap $4.62B
- Description
- Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...